Enabling a four-fold increase in titer for mAb manufacturing using Syngene’s platform process

Learn how Syngene’s platform approach to mAb manufacturing helped a biopharma company achieve a four-fold increase in titer in less than a year, resulting in improved efficiency and reduced costs.